Company Filing History:
Years Active: 2012-2014
Title: Innovations of Charles S. Bay in Flow Cytometry
Introduction
Charles S. Bay is an accomplished inventor based in Fort Collins, CO (US). He has made significant contributions to the field of flow cytometry, holding 2 patents that enhance the capabilities of particle sorting technologies. His work is instrumental in advancing the efficiency and accuracy of flow cytometers.
Latest Patents
One of his notable patents is focused on a flow cytometer sorter. This invention discloses computer-implemented methods for sorting particles from a particle stream in a flow cytometer. The methods involve calculating sort decision-making parameters using raw event data values from the flow cytometer and a defined sort logic. Additionally, it includes performing sort logic computations to generate sort decisions, converting these decisions into sort commands, and sending them to the flow cytometer. The sort logic computations may utilize conditional branching logic and mathematical functions that characterize regions of interest in multidimensional data space. These functions can be tailored based on user-provided parameters, showcasing the adaptability of the system.
Career Highlights
Charles S. Bay is currently associated with Beckman Coulter, Inc., a company renowned for its innovative solutions in laboratory instruments and diagnostics. His work at Beckman Coulter has allowed him to apply his expertise in flow cytometry and contribute to the development of advanced sorting technologies.
Collaborations
Throughout his career, Charles has collaborated with notable colleagues, including Jeffrey W. Degeal and Edward Allan Stanton. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Charles S. Bay's contributions to flow cytometry through his patents and work at Beckman Coulter, Inc. highlight his role as a key innovator in the industry. His advancements in sorting technologies continue to impact the scientific community positively.